In a significant step towards reducing prescription drug costs, the Biden administration has announced that 15 additional medications, including the widely-used weight-loss drugs Ozempic and Wegovy, will be included in the next round of Medicare price negotiations. U.S. Health Secretary emphasized the importance of lowering the prices of targeted medications for seniors. This move is part of the ongoing efforts to make essential drugs more affordable and follows previous announcements regarding negotiations for diabetes and cancer treatments. Stakeholders expect that the negotiated prices could also influence commercial markets, potentially benefiting a broader range of patients.